News

The latest insights, sector developments and case updates from Potter Clarkson. Explore up-to-date content from our experts and stay informed on the issues shaping the IP landscape.

A new lead candidate brings vaccine for Chagas disease closer to reality

When you hear “kissing bug,” you might picture something harmless or even endearing. But this insect delivers anything but affection; it transmits Trypanosoma cruzi, the parasite responsible for Chagas disease, a potentially deadly illness affecting millions worldwide.

Biotech
Life Sciences
Patents
IP Strategy
Potter Clarkson Ranked in IP STARS 2025

Potter Clarkson ranked in Managing IP's IP STARS 2025

Potter Clarkson has been proudly recognised in Managing IP’s IP STARS 2025 rankings.

No items found.
No items found.
UK comparable trade marks: grace period ends soon

UK comparable trade marks: grace period ends soon

As 2025 draws to a close, brand owners face an important deadline that could affect their UK trade mark rights. From 1 January 2026, it is no longer possible to rely on evidence of use in the EU to maintain the validity of UK comparable trade marks (often called “Brexit clones”). This marks the end of the grace period for use, originally set out in the UK/EU Withdrawal Agreement.

No items found.
Trade Marks
The Legal 500 2026

The Legal 500 2026

Potter Clarkson has once again been highly recognised in the 2026 Legal 500 rankings, a leading guide for clients seeking top law firms, attorneys, and solicitors.

No items found.
No items found.
UPC grants first UK injunction

UPC grants first UK injunction

Following its previous widely-reported ruling earlier this year, the Mannheim Local Division has now issued its decision in respect of the UK aspect of the infringement proceedings brought by FujiFilm, marking the first time that the UPC has granted an injunction which applies to the UK.

Creative Industries
Electronics & Computing
Patents
UPC Litigation
What should I be asking IP firms to present in a tender?

What should I be asking IP firms to present in a tender?

Intellectual property (IP) is one of the most valuable assets a business can hold. Patents, trade marks, copyrights, and trade secrets are not just legal formalities, they are hugely valuable strategic tools that protect innovation and create competitive advantage.

No items found.
IP Strategy
Can space agriculture tackle the food crisis and how is IP enforced in space?

Can space agriculture tackle the food crisis and how is IP enforced in space?

Space agriculture (or as you may know it, space-based AgTech, astroagriculture, exo-agriculture, off-earth farming or extraterrestrial food systems) refers to agricultural technologies and systems developed or tested in space.

Biotech
Food & Agritech
Spacetech
Synthetic Biology
Freedom to Operate
IP Strategy
Licensing & Commercial Agreements
Patents
Potter Clarkson launches landmark patent landscape analysis of the SynBio revolution

Potter Clarkson launches landmark patent landscape analysis of the SynBio revolution

From engineered microbes cleaning up environmental waste to CRISPR-edited cells powering next-generation therapies, synthetic biology is shaping industries, economies, and everyday life.

Biotech
Synthetic Biology
Artificial Intelligence
IP Strategy
Patents

The SPC manufacturing waiver in practice: legal framework and emerging jurisprudence

The SPC manufacturing waiver, introduced in 2019 under Regulation (EU) No 2019/933, marked a pivotal development in EU pharmaceutical law.

Life Sciences
SPCs & Regulatory
Patents
Can CRISPR and RNAi help us develop new and more sustainable fruits and vegetables?

Can CRISPR and RNAi help us develop new and more sustainable fruits and vegetables?

Gene editing technologies like CRISPR and RNA interference (RNAi) are revolutionising agriculture.

Biotech
Food & Agritech
Synthetic Biology
Patents
What are the critical success factors procurement managers should prioritise when selecting an IP firm from tender responses?

What are the critical success factors procurement managers should prioritise when selecting an IP firm from tender responses?

When evaluating tender responses from IP law firms, procurement managers should prioritise the direct responses to their critical success factors (CSFs). This will ensure the selected firm is capable of delivering value and minimising risk.

No items found.
No items found.
Referral on EPO description amendments confirmed (G1/25 - “Hydroponics")

Referral on EPO description amendments confirmed (G1/25 - “Hydroponics")

A Board of Appeal at the EPO has referred questions to the Enlarged Board of Appeal (EBA) in connection with inconsistencies between the claims and description of a European patent vs. those of a European patent application (pre-grant vs. post-grant).

Life Sciences
EPO Oppositions
Patents

Helping a green hydrogen technology company scale through strategic IP

GeoPura is a trailblazer within sustainable innovation. They provide a zero-emission solution for generating, storing, and distributing the energy needed to drive the global transition to clean power by giving customers the power to decarbonize their consumption of temporary, backup, off-grid, and grid augmentation energy.

We worked with this pioneering clean energy business to put in place the patent and trade mark protection needed to support the development and commercialisation of its hydrogen power technology and HPU™ brand. This strategy helped secure investment and accelerate growth.

Energy & Cleantech
Fuel Cells & Hydrogen
IP Strategy
Patents
Trade Marks
Investor Ready
UK approach to plausibility remains unchanged despite EPO’s G2/21

UK approach to plausibility remains unchanged despite EPO’s G2/21

In the recent decision Generics v AstraZeneca, the UK Court of Appeal confirmed that the UK’s approach to ‘plausibility’ remains unchanged despite the EPO Enlarged Board of Appeal decision G2/21.

Life Sciences
EPO Oppositions
Patents
Proposed reforms to regulatory exclusivities from the European Parliament and Council

Proposed reforms to regulatory exclusivities from the European Parliament and Council

In April 2023, the European Commission adopted a comprehensive package of proposed reforms to the legislation governing the authorisation of medicines in the EU.

Life Sciences
Patents
SPCs & Regulatory

New UPC CMS launched

The revamped UPC Case Management System (‘CMS’) is now live. The objective of the new CMS is to simplify access for users. This will be a welcome update for IP practitioners who have in the past experienced various issues when using the old CMS.

No items found.
Patents
UPC Litigation